A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

NCT07219589 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Obese

Interventions

DRUG: HM17321
DRUG: Placebo of HM17321

Sponsor

Hanmi Pharmaceutical Company Limited